Splenic Neoplasm — Trials

Splenic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

170 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07583810	Non-covalent BTK Inhibitor Nemtabrutinib in Combination With the CD20 Monoclonal Antibody Rituximab for the Treatment of Marginal Zone Lymphoma	recruiting	Phase 2	35	City of Hope Medical CenterOTHER	1	Sep 29, 2026	clinicaltrials
NCT01841723	Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia	active not recruiting	Phase 2	44	National Cancer Institute (NCI)NIH	1	Sep 15, 2026	clinicaltrials